| Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, ... Gastroenterology 148 (7), 1340-1352. e7, 2015 | 933 | 2015 |
| Liver injury from herbals and dietary supplements in the US Drug‐Induced Liver Injury Network VJ Navarro, H Barnhart, HL Bonkovsky, T Davern, RJ Fontana, L Grant, ... Hepatology 60 (4), 1399-1408, 2014 | 485 | 2014 |
| Hepatic histological findings in suspected drug‐induced liver injury: systematic evaluation and clinical associations DE Kleiner, NP Chalasani, WM Lee, RJ Fontana, HL Bonkovsky, ... Hepatology 59 (2), 661-670, 2014 | 412 | 2014 |
| Drug-induced hepatotoxicity N KAPLOWITZ, TY Aw, FR SIMON, A STOLZ Annals of internal medicine 104 (6), 826-839, 1986 | 369 | 1986 |
| Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset RJ Fontana, PH Hayashi, J Gu, KR Reddy, H Barnhart, PB Watkins, ... Gastroenterology 147 (1), 96-108. e4, 2014 | 260 | 2014 |
| Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study P Nicoletti, GP Aithal, ES Bjornsson, RJ Andrade, A Sawle, M Arrese, ... Gastroenterology 152 (5), 1078-1089, 2017 | 230 | 2017 |
| United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts HA Oketch-Rabah, AL Roe, CV Rider, HL Bonkovsky, GI Giancaspro, ... Toxicology reports 7, 386-402, 2020 | 160 | 2020 |
| Clinical and histologic features of azithromycin-induced liver injury MA Martinez, R Vuppalanchi, RJ Fontana, A Stolz, DE Kleiner, ... Clinical gastroenterology and hepatology 13 (2), 369-376. e3, 2015 | 153 | 2015 |
| cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family A Stolz, L Hammond, H Lou, H Takikawa, M Ronk, JE Shively Journal of Biological Chemistry 268 (14), 10448-10457, 1993 | 153 | 1993 |
| Identification, purification, and immunochemical characterization of a tocopherol-binding protein in rat liver cytosol. H Yoshida, M Yusin, I Ren, J Kuhlenkamp, T Hirano, A Stolz, N Kaplowitz Journal of Lipid Research 33 (3), 343-350, 1992 | 150 | 1992 |
| Bile acid transport RJ Bahar, A Stolz Gastroenterology Clinics of North America 28 (1), 27-58, 1999 | 146 | 1999 |
| Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗ 35: 02 as a risk factor TJ Urban, P Nicoletti, N Chalasani, J Serrano, A Stolz, AK Daly, GP Aithal, ... Journal of hepatology 67 (1), 137-144, 2017 | 129 | 2017 |
| Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling Q Ji, C Aoyama, YD Nien, PI Liu, PK Chen, L Chang, FZ Stanczyk, A Stolz Cancer research 64 (20), 7610-7617, 2004 | 125 | 2004 |
| Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs TJ Urban, Y Shen, A Stolz, N Chalasani, RJ Fontana, J Rochon, D Ge, ... Pharmacogenetics and genomics 22 (11), 784-795, 2012 | 121 | 2012 |
| Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury RJ Fontana, PH Hayashi, H Barnhart, DE Kleiner, RK Reddy, N Chalasani, ... Official journal of the American College of Gastroenterology| ACG 110 (10 …, 2015 | 117 | 2015 |
| The role of cytoplasmic proteins in hepatic bile acid transport A Stolz, H Takikawa, M Ookhtens, N Kaplowitz Annual Review of Physiology 51 (1), 161-176, 1989 | 117 | 1989 |
| Induction of AKR1C2 by phase II inducers: identification of a distal consensus antioxidant response element regulated by NRF2 H Lou, S Du, Q Ji, A Stolz Molecular pharmacology 69 (5), 1662-1672, 2006 | 113 | 2006 |
| A missense variant in PTPN22 is a risk factor for drug-induced liver injury ET Cirulli, P Nicoletti, K Abramson, RJ Andrade, ES Bjornsson, ... Gastroenterology 156 (6), 1707-1716. e2, 2019 | 112 | 2019 |
| Liver injury from nonsteroidal anti‐inflammatory drugs in the United States PA Schmeltzer, AS Kosinski, DE Kleiner, JH Hoofnagle, A Stolz, ... Liver international 36 (4), 603-609, 2016 | 109 | 2016 |
| Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism Q Ji, L Chang, D VanDenBerg, FZ Stanczyk, A Stolz The Prostate 54 (4), 275-289, 2003 | 103 | 2003 |
